In addition, we obtained drug screen data from the “Genomics of Drug Sensitivity in Cancer” database (Yang et al., 2013) for two TNF pathway compounds that inhibit TRAF2 binding partners, BIRC2/BIRC3 (IAP-5620) and BIRC2 (AZD5582). Here, TNF is linked to cancer.